IFTAK(应用Ksharasutra阻断瘘道)技术:一种微创治疗复发性静脉瘘的病例系列分析。

IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Awadhesh Kumar Pandey, Shivani Katkar, Saradhi R, Naresh Parmar, Aadithyaraj K T, Arun Kumar Dwivedi, Rahul Sherkhane
{"title":"IFTAK(应用Ksharasutra阻断瘘道)技术:一种微创治疗复发性静脉瘘的病例系列分析。","authors":"Awadhesh Kumar Pandey, Shivani Katkar, Saradhi R, Naresh Parmar, Aadithyaraj K T, Arun Kumar Dwivedi, Rahul Sherkhane","doi":"10.1007/s00384-025-04900-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the case series analysis is to explore the multifactorial causes of recurrent fistula-in-ano, highlighting the limitations of conventional treatment methods, and to evaluate the potential of the IFTAK (Interception of the Fistulous Tract with Application of Ksharsutra) technique. By addressing challenges such as incontinence and relapse associated with recurrent fistulas, the study aims to demonstrate how the IFTAK approach, with its sphincter-sparing and healing-promoting properties, offers an effective and sustainable solution for better management and reduced recurrence rates.</p><p><strong>Methods: </strong>This retrospective study involved 10 patients with recurrent fistula-in-ano, consecutively selected on the basis of the date of intervention and treated using the IFTAK technique. Preoperative imaging and clinical assessments identified the fistulous tract. Intraoperatively, the tract was intercepted at the inter-sphincteric plane, followed by Ksharasutra application. Postoperative care included sitz baths, dressing changes, and weekly thread replacement until healing.</p><p><strong>Results: </strong>Among 10 patients (8 males, 2 females; average age 39 years), cut-through was achieved in 2-3 months, depending on the fistula complexity. Weekly follow-ups ensured healing, with no recurrence observed in 10 patients over 12 months (1 year).</p><p><strong>Conclusion: </strong>IFTAK is a minimally invasive and effective technique for managing complex and recurrent fistula-in-ano, offering reduced recurrence, sphincter preservation, and faster recovery. Further randomized trials are needed to establish its long-term efficacy with an extended follow-up period and universal applicability.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"155"},"PeriodicalIF":2.5000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12254057/pdf/","citationCount":"0","resultStr":"{\"title\":\"IFTAK (Interception of Fistulous Tract with Application of Ksharasutra) technique: a minimally invasive solution for recurrent fistula-in-ano-a case series analysis.\",\"authors\":\"Awadhesh Kumar Pandey, Shivani Katkar, Saradhi R, Naresh Parmar, Aadithyaraj K T, Arun Kumar Dwivedi, Rahul Sherkhane\",\"doi\":\"10.1007/s00384-025-04900-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The purpose of the case series analysis is to explore the multifactorial causes of recurrent fistula-in-ano, highlighting the limitations of conventional treatment methods, and to evaluate the potential of the IFTAK (Interception of the Fistulous Tract with Application of Ksharsutra) technique. By addressing challenges such as incontinence and relapse associated with recurrent fistulas, the study aims to demonstrate how the IFTAK approach, with its sphincter-sparing and healing-promoting properties, offers an effective and sustainable solution for better management and reduced recurrence rates.</p><p><strong>Methods: </strong>This retrospective study involved 10 patients with recurrent fistula-in-ano, consecutively selected on the basis of the date of intervention and treated using the IFTAK technique. Preoperative imaging and clinical assessments identified the fistulous tract. Intraoperatively, the tract was intercepted at the inter-sphincteric plane, followed by Ksharasutra application. Postoperative care included sitz baths, dressing changes, and weekly thread replacement until healing.</p><p><strong>Results: </strong>Among 10 patients (8 males, 2 females; average age 39 years), cut-through was achieved in 2-3 months, depending on the fistula complexity. Weekly follow-ups ensured healing, with no recurrence observed in 10 patients over 12 months (1 year).</p><p><strong>Conclusion: </strong>IFTAK is a minimally invasive and effective technique for managing complex and recurrent fistula-in-ano, offering reduced recurrence, sphincter preservation, and faster recovery. Further randomized trials are needed to establish its long-term efficacy with an extended follow-up period and universal applicability.</p>\",\"PeriodicalId\":13789,\"journal\":{\"name\":\"International Journal of Colorectal Disease\",\"volume\":\"40 1\",\"pages\":\"155\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12254057/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Colorectal Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00384-025-04900-2\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00384-025-04900-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本病例系列分析的目的是探讨复发性瘘管的多因素原因,突出传统治疗方法的局限性,并评估IFTAK (Ksharsutra阻断瘘道)技术的潜力。通过解决与复发性瘘管相关的尿失禁和复发等挑战,该研究旨在展示IFTAK方法如何利用其保留括约肌和促进愈合的特性,为更好的管理和降低复发率提供有效和可持续的解决方案。方法:回顾性研究10例复发性瘘管患者,根据干预日期连续选择,采用IFTAK技术治疗。术前影像学和临床评估确定了瘘道。术中,在括约肌间平面截留该束,随后应用Ksharasutra。术后护理包括坐浴、换药、每周更换缝线直至愈合。结果:10例患者中,男8例,女2例;平均年龄39岁),根据瘘管的复杂程度,在2-3个月内切开。每周随访确保愈合,10例患者在12个月(1年)内未观察到复发。结论:IFTAK是一种微创、有效的治疗复杂和复发性瘘管的技术,可减少复发,保留括约肌,恢复更快。需要进一步的随机试验来确定其长期疗效、延长随访期和普遍适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
IFTAK (Interception of Fistulous Tract with Application of Ksharasutra) technique: a minimally invasive solution for recurrent fistula-in-ano-a case series analysis.

Purpose: The purpose of the case series analysis is to explore the multifactorial causes of recurrent fistula-in-ano, highlighting the limitations of conventional treatment methods, and to evaluate the potential of the IFTAK (Interception of the Fistulous Tract with Application of Ksharsutra) technique. By addressing challenges such as incontinence and relapse associated with recurrent fistulas, the study aims to demonstrate how the IFTAK approach, with its sphincter-sparing and healing-promoting properties, offers an effective and sustainable solution for better management and reduced recurrence rates.

Methods: This retrospective study involved 10 patients with recurrent fistula-in-ano, consecutively selected on the basis of the date of intervention and treated using the IFTAK technique. Preoperative imaging and clinical assessments identified the fistulous tract. Intraoperatively, the tract was intercepted at the inter-sphincteric plane, followed by Ksharasutra application. Postoperative care included sitz baths, dressing changes, and weekly thread replacement until healing.

Results: Among 10 patients (8 males, 2 females; average age 39 years), cut-through was achieved in 2-3 months, depending on the fistula complexity. Weekly follow-ups ensured healing, with no recurrence observed in 10 patients over 12 months (1 year).

Conclusion: IFTAK is a minimally invasive and effective technique for managing complex and recurrent fistula-in-ano, offering reduced recurrence, sphincter preservation, and faster recovery. Further randomized trials are needed to establish its long-term efficacy with an extended follow-up period and universal applicability.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.90
自引率
3.60%
发文量
206
审稿时长
3-8 weeks
期刊介绍: The International Journal of Colorectal Disease, Clinical and Molecular Gastroenterology and Surgery aims to publish novel and state-of-the-art papers which deal with the physiology and pathophysiology of diseases involving the entire gastrointestinal tract. In addition to original research articles, the following categories will be included: reviews (usually commissioned but may also be submitted), case reports, letters to the editor, and protocols on clinical studies. The journal offers its readers an interdisciplinary forum for clinical science and molecular research related to gastrointestinal disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信